SSA
BMY icon

Schonfeld Strategic Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.11M Sell
155,418
-252,821
-62% -$14.7M 0.06% 325
2025
Q4 		$22M Sell
408,239
-769,862
-65% -$37M 0.1% 176
2025
Q3 		$52.9M Buy
1,178,101
+1,152,283
+4,463% +$53.8M 0.3% 39
2025
Q2 		$1.2M Buy
+25,818
New +$1.27M 0.01% 1225
2025
Q1 		– Sell
-664,205
Closed -$37.6M – 2213
2024
Q4 		$37.6M Buy
664,205
+206,404
+45% +$11.5M 0.22% 64
2024
Q3 		$23.7M Sell
457,801
-595,112
-57% -$27.9M 0.16% 101
2024
Q2 		$43.7M Buy
1,052,913
+692,621
+192% +$31M 0.28% 49
2024
Q1 		$19.5M Buy
360,292
+133,435
+59% +$6.8M 0.13% 175
2023
Q4 		$11.6M Buy
226,857
+132,506
+140% +$6.96M 0.08% 308
2023
Q3 		$5.48M Buy
94,351
+85,812
+1,005% +$5.26M 0.04% 519
2023
Q2 		$546K Sell
8,539
-121,663
-93% -$8.16M ﹤0.01% 1191
2023
Q1 		$9.02M Sell
130,202
-196,475
-60% -$13.9M 0.09% 311
2022
Q4 		$23.5M Buy
326,677
+218,577
+202% +$16.5M 0.2% 137
2022
Q3 		$7.68M Sell
108,100
-1,539
-1% -$112K 0.06% 393
2022
Q2 		$8.44M Sell
109,639
-1,995
-2% -$152K 0.08% 324
2022
Q1 		$8.15M Buy
111,634
+103,034
+1,198% +$6.92M 0.07% 312
2021
Q4 		$537K Sell
8,600
-113,239
-93% -$6.64M ﹤0.01% 1225
2021
Q3 		$7.21M Buy
121,839
+42,401
+53% +$2.79M 0.07% 338
2021
Q2 		$5.31M Sell
79,438
-90,502
-53% -$5.9M 0.06% 444
2021
Q1 		$10.7M Buy
169,940
+150,240
+763% +$9.35M 0.13% 212
2020
Q4 		$1.22M Sell
19,700
-66,475
-77% -$4.09M 0.02% 745
2020
Q3 		$5.2M Buy
86,175
+1,063
+1% +$64K 0.1% 278
2020
Q2 		$5M Buy
85,112
+69,481
+445% +$4.16M 0.13% 230
2020
Q1 		$871K Sell
15,631
-41,569
-73% -$2.54M 0.05% 414
2019
Q4 		$3.67M Buy
+57,200
New +$3.28M 0.09% 244
2019
Q3 		– Sell
-10,400
Closed -$472K – 1024
2019
Q2 		$472K Sell
10,400
-251,600
-96% -$11.7M 0.02% 651
2019
Q1 		$12.5M Buy
+262,000
New +$13.1M 0.43% 49
2018
Q4 		– Sell
-28,400
Closed -$1.76M – 1062
2018
Q3 		$1.76M Buy
28,400
+14,149
+99% +$840K 0.08% 313
2018
Q2 		$789K Buy
+14,251
New +$770K 0.04% 438
2018
Q1 		– Sell
-22,256
Closed -$1.36M – 764
2017
Q4 		$1.36M Buy
22,256
+14,490
+187% +$906K 0.11% 247
2017
Q3 		$495K Buy
7,766
+2,149
+38% +$125K 0.05% 381
2017
Q2 		$313K Sell
5,617
-44,383
-89% -$2.42M 0.03% 465
2017
Q1 		$2.72M Buy
50,000
+40,000
+400% +$2.19M 0.27% 108
2016
Q4 		$584K Sell
10,000
-44,797
-82% -$2.45M 0.08% 312
2016
Q3 		$2.95M Buy
+54,797
New +$3.52M 0.5% 51
2016
Q2 		– Sell
-12,000
Closed -$767K – 440
2016
Q1 		$767K Buy
+12,000
New +$757K 0.31% 91

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's BMY Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Bristol-Myers Squibb (BMY) stake by 62% in Q1 2026, selling an estimated $14.7M and leaving 155,418 shares worth $9.11M. The position accounts for 0.06% of the portfolio, ranked #325.

Schonfeld Strategic Advisors first reported a position in BMY in Q1 2016 and has held it in 36 quarters since. The position peaked at $52.9M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Schonfeld Strategic Advisors held 155,418 shares of Bristol-Myers Squibb worth $9.11M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 252,821 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.7M.
  • Bristol-Myers Squibb made up 0.06% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #325 holding.
  • Schonfeld Strategic Advisors first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 36 quarters since.
  • Schonfeld Strategic Advisors's Bristol-Myers Squibb position peaked at $52.9M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.